A number of other equities research analysts have also weighed in on STKL. Zacks Investment Research lowered shares of SunOpta from a hold rating to a sell rating in a report on Tuesday, May 14th. BidaskClub raised shares of SunOpta from a strong sell rating to a sell rating in a research note on Friday, April 26th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of $10.00.
Shares of STKL traded up $0.18 during mid-day trading on Friday, reaching $4.51. The company’s stock had a trading volume of 699,270 shares, compared to its average volume of 297,667. The firm has a market cap of $395.00 million, a price-to-earnings ratio of -16.11 and a beta of 1.13. The company has a debt-to-equity ratio of 1.86, a quick ratio of 0.38 and a current ratio of 1.30. SunOpta has a 52 week low of $2.21 and a 52 week high of $9.10.
In other news, SVP Mike Buick bought 30,000 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were bought at an average cost of $2.67 per share, with a total value of $80,100.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard Dean Hollis bought 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 28th. The stock was purchased at an average cost of $2.68 per share, for a total transaction of $268,000.00. Following the completion of the purchase, the director now owns 230,035 shares of the company’s stock, valued at $616,493.80. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 378,202 shares of company stock worth $1,266,913. 1.75% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of SunOpta by 97.0% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 7,269,857 shares of the company’s stock worth $28,134,000 after buying an additional 3,578,928 shares during the period. FMR LLC increased its stake in shares of SunOpta by 5.4% in the first quarter. FMR LLC now owns 3,638,784 shares of the company’s stock worth $12,590,000 after buying an additional 186,718 shares during the period. Morgan Stanley increased its stake in shares of SunOpta by 4.8% in the first quarter. Morgan Stanley now owns 3,301,719 shares of the company’s stock worth $11,425,000 after buying an additional 150,113 shares during the period. Thrivent Financial for Lutherans purchased a new position in SunOpta during the 4th quarter valued at $11,646,000. Finally, Factory Mutual Insurance Co. increased its position in SunOpta by 18.7% during the 1st quarter. Factory Mutual Insurance Co. now owns 2,576,700 shares of the company’s stock valued at $9,173,000 after purchasing an additional 405,300 shares during the period. 81.78% of the stock is currently owned by institutional investors.
SunOpta Company Profile
SunOpta Inc sources non-genetically modified (non-GMO) and organic ingredients; and manufactures food and beverage products in the United States, Canada, Europe, and internationally. The company operates through Global Ingredients and Consumer Products segments. The Global Ingredients segment offers organic fruit- and vegetable-based raw materials and ingredients, sweeteners, cocoa, coffees, ancient grains, nuts, seeds and pulses, and other organic food products; identity preserved, non-GMO, and organic seeds and grains, including soy, corn, and sunflower; and seed and grain-based animal feed, and pet food products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.